Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION

(RAD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Rite Aid : investors vote 5-1 against $3M bonus for CEO whose deals failed

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/30/2018 | 12:04pm EDT

Oct. 30--Shares of Rite Aid, the Camp Hill, Pa.-based drugstore chain, rose 3 cents to $1.08 in trading Tuesday after 84 percent of shareholders voted against the company's proposed executive pay package including a $3 million bonus for chief executive John T. Standley, according to the International Brotherhood of Teamsters labor union, which represents some Rite Aid workers and holds shares in the struggling company.

While such votes are typically not binding on managers, the Rite Aid outcome shows investor disgust with the company, whose shares have fallen from over $7 a share in 2017 to less than $1 last month after merger deals with rival Walgreens and with Acme's owner Albertsons unraveled. Rite Aid and other discount drug chains also face strong retail competition and market and insurer resistance to higher drug prices.

Standley has agreed to step down as chairman of Rite Aid, now a 2,000-store chain after selling stores to Walgreens' in lieu of a sale last year. His replacement as chairman is Bruce G. Bodaken, a former chairman and CEO of Blue Shield of California. Standley remains as Rite Aid chief executive officer.

"CEO Standley must rebuild trust," said Ken Hall, general secretary of the Teamsters, in a statement.

"Anybody else in CEO Standley's position would be out of a job by now," he added. He said executives' attempts to reward themselves at many times the salaries hourly workers earn, at a time when Rite Aid has been closing stores, "erodes morale."

A company spokesman was not immediately available for comment. Troubled corporations often justify extra pay on grounds it is hard to recruit and keep executives when they are worried a company could be the subject of negative publicity. Companies also justify large bonuses when a company is doing well.

___

(c)2018 The Philadelphia Inquirer

Visit The Philadelphia Inquirer at www.philly.com

Distributed by Tribune Content Agency, LLC.

© Tribune Content Agency, source Regional News

Stocks mentioned in the article
ChangeLast1st jan.
RITE AID CORPORATION 10.60% 10.75 Delayed Quote.-24.11%
WALGREENS BOOTS ALLIANCE -0.97% 54.1 Delayed Quote.-20.83%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
04/22RITE AID CORPORATION : REVERSE SPLIT: 1 of 20
FA
04/16RITE AID : leader shares insight on its successful e-commerce strategy
AQ
04/16RITE AID : Measles-Mumps-Rubella Vaccine Available at Rite Aid Pharmacies Nation..
BU
04/15RITE AID CORP : Change in Directors or Principal Officers, Regulation FD Disclos..
AQ
04/15RITE AID : Appoints Elizabeth Burr and Katherine Quinn to Board of Directors
BU
04/11RITE AID : cuts 95% of outstanding shares to hit NYSE minimum
AQ
04/11RITE AID : Fiscal 4Q Earnings Snapshot
AQ
04/11RITE AID CORP : Results of Operations and Financial Condition, Financial Stateme..
AQ
04/11RITE AID : Reports Fiscal 2019 Fourth Quarter and Full Year Results
BU
04/11RITE AID CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,..
AQ
More news
Financials ($)
Sales 2020 21 548 M
EBIT 2020 -
Net income 2020 -113 M
Debt 2020 3 255 M
Yield 2020 -
P/E ratio 2020 -
P/E ratio 2021
Capi. / Sales 2020 0,18x
Capi. / Sales 2021 0,02x
Capitalization 525 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Average target price 0,45 $
Spread / Average Target -7,4%
EPS Revisions
Managers
NameTitle
John T. Standley Chief Executive Officer & Director
Kermit R. Crawford President & Chief Operating Officer
Bruce G. Bodaken Chairman
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Justin Mennen Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-24.11%525
RAIA DROGASIL13.88%5 477
AIN HOLDINGS INC13.82%2 763
QOL HOLDINGS CO LTD2.89%571
NIHON CHOUZAI CO.,LTD.27.17%555
AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD4.71%509